Every article, report, and earnings note where DOCS appears.
TEM’s 24.1% headline-free surge looks like investors repricing a real profitability inflection, not chasing an empty AI story. Q2 revenue growth, a guidance raise and a path to positive cash flow give the rally a fundamental anchor despite expensive valuation.
TEM's 13% surge is running ahead of an unprofitable business and a $1.5 billion Personalis deal that adds scale before it adds clean earnings. Strong revenue growth is real, but dilution, cash needs, and insider selling make this rally one to fade rather than chase.
Tempus AI is getting sold on supposedly bullish news because the market still does not trust growth financed with more paper. The Personalis deal, fresh convert dilution, and persistent losses are colliding with a stock that was never priced for execution mistakes.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate DOCS ReportCancel anytime